Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -19.77 | — | — | — | — | 43.47 | — | 60.15 | 21.77 | 17.22 | 11.70 | 6.89 | 6.33 |
| — | — | — | — | — | +152.5% | — | +773.2% | +244.1% | +125.7% | +214.5% | +107.3% | +88.7% | |
| P/S Ratio | 0.21 | 0.46 | 0.39 | 0.41 | 0.47 | 0.35 | 0.35 | 0.43 | 0.47 | 0.49 | 0.46 | 0.33 | 0.39 |
| — | +31.0% | +11.8% | -4.1% | -0.1% | -28.4% | -25.0% | +30.3% | +21.4% | +17.8% | +76.8% | +25.6% | -4.5% | |
| P/B Ratio | 0.69 | 1.13 | 1.03 | 1.15 | 1.40 | 1.05 | 1.07 | 1.38 | 1.66 | 1.86 | 2.12 | 1.81 | 2.15 |
| — | +8.2% | -3.9% | -16.9% | -15.5% | -43.6% | -49.5% | -23.4% | -22.7% | -26.3% | +10.8% | -21.9% | -39.1% | |
| P/FCF | 2.52 | 6.44 | 47.11 | 31.67 | 6.76 | 17.50 | 1.48 | 42.60 | 21.34 | 3.26 | 2.16 | 4.72 | 106.78 |
| — | -63.2% | +3089.7% | -25.7% | -68.3% | +437.4% | -31.7% | +801.8% | -80.0% | +68.7% | -82.0% | — | — | |
| EV / EBITDA | 319.77 | — | — | 26.57 | 612.38 | 13.08 | — | 21.38 | 11.12 | 8.68 | 6.53 | 4.94 | 5.25 |
| — | — | — | +24.2% | +5409.0% | +50.7% | — | +333.2% | +111.6% | +64.0% | +114.3% | +73.9% | +33.1% | |
| EV / EBIT | — | — | — | — | 373.53 | 24.42 | — | 19.93 | 13.50 | 10.70 | 7.06 | 5.30 | 5.51 |
| — | — | — | — | +2666.5% | +128.3% | — | +276.1% | +144.8% | +113.5% | +118.8% | +85.8% | +35.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cross Country Healthcare, Inc.'s operating margin was -2.4% in Q3 2025, down 0.3 pp QoQ and down 3.3 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.4% | 20.4% | 20.4% | 20.0% | 20.0% | 20.4% | 20.8% | 20.4% | 21.9% | 22.0% | 22.8% | 22.4% | 22.1% |
| — | +0.0% | -1.9% | -1.9% | -8.5% | -7.5% | -8.5% | -9.0% | -1.2% | -2.5% | +0.7% | +1.0% | -3.7% | |
| Operating Margin | -1.3% | -2.4% | -2.1% | -0.3% | -1.1% | 0.9% | -5.7% | 0.8% | 3.2% | 4.6% | 6.5% | 7.0% | 8.2% |
| — | -363.8% | +62.2% | -143.2% | -134.2% | -80.3% | -186.9% | -89.0% | -60.4% | -44.0% | -37.8% | -38.8% | -30.9% | |
| Net Margin | -1.1% | -1.9% | -2.4% | -0.2% | -1.2% | 0.8% | -4.7% | 0.7% | 2.2% | 2.9% | 3.9% | 4.7% | 6.2% |
| — | -335.5% | +48.6% | -123.5% | -155.5% | -72.0% | -219.7% | -85.0% | -64.6% | -47.0% | -43.8% | -39.8% | -49.0% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.3% | -1.2% | -1.6% | -0.1% | -0.9% | 0.6% | -3.5% | 0.6% | 1.9% | 2.7% | 4.6% | 6.5% | 8.8% |
| — | -296.7% | +54.7% | -120.5% | -146.4% | -78.3% | -176.4% | -91.2% | -78.3% | -67.3% | -66.4% | -65.9% | -70.8% | |
| ROA | -2.3% | -0.9% | -1.2% | -0.1% | -0.6% | 0.4% | -2.6% | 0.4% | 1.3% | 1.7% | 2.5% | 3.2% | 4.2% |
| — | -305.4% | +54.1% | -120.7% | -148.5% | -75.4% | -201.7% | -87.1% | -69.3% | -54.6% | -55.7% | -58.1% | -65.8% | |
| ROIC | -3.2% | -1.4% | -1.3% | -0.2% | -0.7% | 0.6% | -3.4% | 0.5% | 2.2% | 3.1% | 4.8% | 5.4% | 6.8% |
| — | -339.9% | +61.9% | -145.6% | -133.4% | -81.6% | -171.6% | -91.3% | -67.7% | -53.4% | -50.7% | -56.6% | -51.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 23.7% YoY to 3.45x, strengthening the short-term liquidity position. Debt/Equity has declined for 5 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.08 | 0.32 | 0.35 |
| — | -48.0% | -37.8% | -17.5% | -17.0% | -16.3% | -86.4% | -97.0% | -96.8% | -96.3% | -84.9% | -51.7% | -47.5% | |
| Debt / EBITDA | 6.10 | — | — | 0.87 | 18.61 | 0.60 | — | 0.59 | 0.30 | 0.23 | 0.95 | 3.00 | 2.92 |
| — | — | — | +46.8% | +6046.4% | +155.9% | — | -80.2% | -89.6% | -90.7% | -64.1% | +17.5% | +17.5% | |
| Current Ratio | 2.78 | 3.45 | 3.21 | 2.98 | 2.78 | 2.79 | 3.07 | 3.02 | 2.79 | 2.43 | 2.34 | 2.45 | 2.49 |
| — | +23.7% | +4.8% | -1.1% | -0.4% | +15.0% | +31.0% | +23.2% | +12.3% | +1.7% | -12.5% | +0.2% | -2.2% | |
| Quick Ratio | 2.78 | 3.45 | 3.21 | 2.98 | 2.78 | 2.79 | 3.07 | 3.02 | 2.79 | 2.43 | 2.34 | 2.45 | 2.49 |
| — | +23.7% | +4.8% | -1.1% | -0.4% | +15.0% | +31.0% | +23.2% | +12.3% | +1.7% | -12.5% | +1.3% | -2.2% | |
| Interest Coverage | -7.71 | -10.74 | -10.67 | -1.80 | -5.65 | 5.19 | -33.81 | 6.32 | 22.91 | 30.35 | 11.17 | 11.87 | 14.64 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonCross Country Healthcare, Inc.'s current P/E is -19.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cross Country Healthcare, Inc.'s current operating margin is -1.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cross Country Healthcare, Inc.'s business trajectory between earnings reports.